Feb 17, 2021
0 0

The Ministry of Health approves the beginning of the third phase of trials of the Sputnik Light vaccine

The Russian Ministry of Health approved the transition to the third phase of research on the Sputnik Light vaccine, it follows from the register of approvals for clinical trials.

It is specified that at this stage the immunogenicity and safety of “Sputnik Light” will be investigated.

The head of the Russian Direct Investment Fund, Kirill Dmitriev, previously reported that Sputnik V is a whole platform of vaccines. The “Light” type is focused on deliveries to countries with strong foci of the spread of infection, while Sputnik V remains the main drug in Russia.

Earlier, specialists from the Gamaleya Center began preparing documents for the country’s Ministry of Health to obtain permission to study the Sputnik V coronavirus vaccine in children.

Article Categories:

Leave a Reply